Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP718555.RA3XyLFmP6PhhQ1JdZ6xQ4XOyyIT84uiZTSHNHAXVQHCs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP718555.RA3XyLFmP6PhhQ1JdZ6xQ4XOyyIT84uiZTSHNHAXVQHCs130_assertion type Assertion NP718555.RA3XyLFmP6PhhQ1JdZ6xQ4XOyyIT84uiZTSHNHAXVQHCs130_head.
- NP718555.RA3XyLFmP6PhhQ1JdZ6xQ4XOyyIT84uiZTSHNHAXVQHCs130_assertion description "[The stromelysin-1 genotype was determined for 496 men with coronary artery disease and cholesterol levels between 4.0 and 8.0 mmol/L, participating in the Regression Growth Evaluation Statin Study (REGRESS) study, a clinical trial assessing the effect of the lipid-lowering drug pravastatin on the progression of atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718555.RA3XyLFmP6PhhQ1JdZ6xQ4XOyyIT84uiZTSHNHAXVQHCs130_provenance.
- NP718555.RA3XyLFmP6PhhQ1JdZ6xQ4XOyyIT84uiZTSHNHAXVQHCs130_assertion evidence source_evidence_literature NP718555.RA3XyLFmP6PhhQ1JdZ6xQ4XOyyIT84uiZTSHNHAXVQHCs130_provenance.
- NP718555.RA3XyLFmP6PhhQ1JdZ6xQ4XOyyIT84uiZTSHNHAXVQHCs130_assertion SIO_000772 10190398 NP718555.RA3XyLFmP6PhhQ1JdZ6xQ4XOyyIT84uiZTSHNHAXVQHCs130_provenance.
- NP718555.RA3XyLFmP6PhhQ1JdZ6xQ4XOyyIT84uiZTSHNHAXVQHCs130_assertion wasDerivedFrom befree-20140225 NP718555.RA3XyLFmP6PhhQ1JdZ6xQ4XOyyIT84uiZTSHNHAXVQHCs130_provenance.
- NP718555.RA3XyLFmP6PhhQ1JdZ6xQ4XOyyIT84uiZTSHNHAXVQHCs130_assertion wasGeneratedBy ECO_0000203 NP718555.RA3XyLFmP6PhhQ1JdZ6xQ4XOyyIT84uiZTSHNHAXVQHCs130_provenance.